Latest FDA Product-Specific Guidances Cover Inhalers, Ear Drops And Paxlovid

Agency’s 68 PSGs Include 14 New And 54 Newly-Revised Generic Guidance Documents

 
• By Dave Wallace

The latest batch of product-specific guidances for generic development has been published by the US Food and Drug Administration, covering products that include COVID-19 treatment Paxlovid, ear drops and various metered-dose inhalers.

Number 68 house number plaque
The FDA has published 68 new and newly-revised PSGs • Source: Shutterstock

More from Generics

More from Products